Results 21 to 30 of about 10,682,737 (276)

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome [PDF]

open access: yesBritish Journal of Cancer, 2018
Mutation status of RAS and BRAF, as well as serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), are biomarkers used in clinical management of patients with gastrointestinal cancers.
M. Thomsen   +11 more
semanticscholar   +2 more sources

Occult mucin-producing urothelial-type adenocarcinoma of the prostate with elevated serum levels of carcinoembryonic antigen and carbohydrate antigen 19-9: Report of an autopsy-proven case

open access: yesUrology Case Reports, 2019
Mucin-producing urothelial-type adenocarcinoma of the prostate (MPUAP) is a rare, aggressive neoplasm thought to originate from the prostatic urethral urothelium.
Keisuke Nonaka   +10 more
doaj   +2 more sources

High carbohydrate antigen 19–9 levels indicate poor prognosis in patients with bladder cancer following radical cystectomy [PDF]

open access: yesFrontiers in Oncology
IntroductionOur team previously reported that elevated carbohydrate antigen (CA) 19–9 levels are associated with a worse prognosis in upper tract urothelial carcinoma (UTUC).
Sang Won So   +13 more
doaj   +2 more sources

Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing?

open access: yesGastrointestinal Tumors, 2018
Background: Gastric cancer (GC) is characterized by aggressive behavior and a high mortality rate. The diagnosis of GC is challenging because the GC is often diagnosed in an advanced stage.
A. Kotzev, P. Draganov
semanticscholar   +2 more sources

Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cancer Antigen 125, Prostate-Specific Antigen and Other Cancer Markers: A Primer on Commonly Used Cancer Markers

open access: yesWorld Journal of Oncology, 2023
Cancer markers are molecules produced by cancer cells which may serve to identify the presence of cancer. Cancer markers can be differentiated as serum-based, radiology-based and tissue-based, and are one of the most important tools in diagnosing ...
Shreya Desai, A. Guddati
semanticscholar   +1 more source

Carbohydrate antigen 19-9 — tumor marker: Past, present, and future

open access: yesWorld Journal of Gastrointestinal Surgery, 2020
Carbohydrate antigen 19-9 (CA 19-9) is a cell surface glycoprotein complex most commonly associated with pancreatic ductal adenocarcinoma (PDAC). Koprowski first described it in 1979 using a mouse monoclonal antibody in a colorectal carcinoma cell line ...
Tsinrong Lee, T. Teng, V. Shelat
semanticscholar   +1 more source

Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection. [PDF]

open access: yes, 2001
The carbohydrate antigen 19-9 (CA 19-9), a determinant (sialylated lacto-N-fucopentaose 119) of a circulating oligosaccharide antigen, is a frequently used tumor marker. Echinococcus spp.
Cerny, A   +4 more
core   +3 more sources

Tumor Marker in Early Detection of Malignancies in Type 2 Diabetes: A Case Series Analysis

open access: yesInternational Journal of Diabetes and Technology, 2023
The association between type 2 diabetes mellitus (T2DM) and malignancy has gained significant attention, with a heightened susceptibility to specific cancers.
Jothydev Kesavadev   +5 more
doaj   +1 more source

Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases

open access: yesScientific Reports, 2020
Although carbohydrate antigen 19-9 (CA 19-9) may be elevated in benign diseases, elevated CA 19-9 may cause a fear of cancer and unnecessary follow-up studies. Research on how to approach systematically in this case is very limited.
Sunyoung Kim   +8 more
semanticscholar   +1 more source

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer

open access: yesDiseases, 2021
Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early stages with enhanced screening methods is vital as metastases and recurrences increase mortality.
Leilani Lakemeyer   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy